Authors:
Gislason, H
Vetrhus, M
Horn, A
Hoem, D
Sondenaa, K
Soreide, O
Viste, A
Andren-Sandberg, A
Citation: H. Gislason et al., Endoscopic sphincterotomy in acute gallstone pancreatitis: A prospective study of the late outcome, EURO J SURG, 167(3), 2001, pp. 204-208
Authors:
Ulrich, AB
Schmied, BM
Matsuzaki, H
Lawson, TA
Friess, H
Andren-Sandberg, A
Buchler, MW
Pour, PM
Citation: Ab. Ulrich et al., Increased expression of glutathione S-transferase-pi in the islets of patients with primary chronic pancreatitis but not secondary chronic pancreatitis, PANCREAS, 22(4), 2001, pp. 388-394
Authors:
Schneider, MB
Standop, J
Ulrich, A
Wittel, U
Friess, H
Andren-Sandberg, A
Pour, PM
Citation: Mb. Schneider et al., Expression of nerve growth factors in pancreatic neural tissue and pancreatic cancer, J HIST CYTO, 49(10), 2001, pp. 1205-1210
Authors:
Kawesha, A
Ghaneh, P
Andren-Sandberg, A
Ograed, D
Skar, R
Dawiskiba, S
Evans, JD
Campbell, F
Lemoine, N
Neoptolemos, JP
Citation: A. Kawesha et al., K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), P21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma, INT J CANC, 89(6), 2000, pp. 469-474
Authors:
Neoptolemos, JP
Ghaneh, P
Andren-Sandberg, A
Bramhall, S
Patankar, R
Kleibeuker, JH
Johnson, CD
Citation: Jp. Neoptolemos et al., Treatment of pancreatic exocrine insufficiency after pancreatic resection - Results of a randomized, double-blind, placebo-controlled, crossover study of high vs standard dose pancreatin, INT J PANCR, 25(3), 1999, pp. 171-180
Authors:
Hoglund, M
Gorunova, L
Jonson, T
Dawiskiba, S
Andren-Sandberg, A
Stenman, G
Johansson, B
Citation: M. Hoglund et al., Cytogenetic and FISH analyses of pancreatic carcinoma reveal breaks in 18q11 with consistent loss of 18q12-qter and frequent gain of 18p, BR J CANC, 77(11), 1998, pp. 1893-1899
Authors:
Friess, H
Lu, Z
Andren-Sandberg, A
Berberat, P
Zimmermann, A
Adler, G
Schmid, R
Buchler, MW
Citation: H. Friess et al., Moderate activation of the apoptosis inhibitor bcl-xL worsens the prognosis in pancreatic cancer, ANN SURG, 228(6), 1998, pp. 780-787